Daiichi Sankyo’s PharmaForce To Invest $145 Million to Expand Sterile Manufacturing OperationsBy
PharmaForce, a Columbus, Ohio-based sterile drug product development and manufacturing company, will invest $145 million to expand two of its existing facilities in the area of Columbus, Ohio. The announcement was made by Columbus 2020, an economic development organization for 11 counties in the Columbus, Ohio region.
PharmaForce was acquired by Luitpold Pharmaceuticals in 2009, which is part of Daiichi Sankyo.
PharmaForce will add approximately 140,000 square feet to its facility in New Albany, Ohio to build out its manufacturing and warehouse operations. The company also plans to reconfigure and remodel a portion of the existing warehouse and production space. At its site in Hilliard, Ohio, PharmaForce plans to remodel and add 1,800 square feet to its existing facility with plans to invest in new production equipment and supporting infrastructure.
Construction and remodeling is planned to commence in 2018, with hiring for packaging, mechanical, sterile, quality assurance, and validation beginning in the first quarter of 2018 and late 2018 for the New Albany, Ohio and Hilliard, Ohio facilities, respectively.
Source: Columbus 2020